• Join
  • Login
  • Contact

Search abstracts

Immunogenicity of biosimilars

  • At: Basel (Switzerland) (2008)
  • Type: Presentation
  • By: JISKOOT, Wim (LACDR, Leiden University, Leiden, Netherlands)
  • Co-author(s): Schellekens, Huub (Utrecht University, Utrecht, Netherlands)
  • Abstract:

    Since the introduction of hybridoma and recombinant DNA technologies more than 30 years ago, more than 150 proteins have entered the clinic as hormones, growth factors, immune-modulating agents and monoclonal antibodies. Moreover, hundreds of biopharmaceuticals are in the pipeline. These products are life-saving and/or increase the quality of


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses